- Home
- PEBO vs MLTX Comparison
PEBO vs MLTX Comparison
Compare PEBO & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEBO | MLTX |
|---|---|---|
| Founded | 1902 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PEBO | MLTX |
|---|---|---|
| Price | $32.78 | $17.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $33.50 | $24.80 |
| AVG Volume (30 Days) | 251.7K | ★ 1.2M |
| Earning Date | 04-22-2026 | 06-01-2026 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.99 | N/A |
| Revenue | ★ $197,000.00 | N/A |
| Revenue This Year | $17.29 | N/A |
| Revenue Next Year | $2.97 | N/A |
| P/E Ratio | $10.81 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.21 | $5.95 |
| 52 Week High | $34.33 | $62.75 |
Technical Indicators
Market Signals| Indicator | PEBO | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 57.13 |
| Support Level | $32.70 | $14.84 |
| Resistance Level | $33.40 | $19.15 |
| Average True Range (ATR) | 0.90 | 0.99 |
| MACD | -0.19 | 0.01 |
| Stochastic Oscillator | 43.68 | 54.74 |
Price Performance
Historical ComparisonAbout PEBO Peoples Bancorp Inc.
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.